Inactivating A20 mutations have been reported in marginal zone lymphomas [54] and A20 mRNA expression loss has been found in non-Hodgkin’s lymphoma, Burkitt’s lymphoma, and T-cell lymphoma [55]. This evidence concerns the gene TNFAIP3 and Burkitt lymphoma.